Published: 25 August 2026 | 7.00 AM
Last Updated: 26 August 2026 | 7.00 AM
IPO Snapshot
| Particulars | Details |
|---|---|
| Chanakya View | π‘ Selective Apply |
| Overall Rating | βββΒ½β (3.5/5) |
| GMP Today | Updated Daily |
| Issue Size | Rs. 14.58 Crore |
| Fresh Issue | 27,00,000 Shares |
| Price Band | Rs. 51βRs. 54 |
| Lot Size | 2,000 Shares |
| Minimum Retail Application | 4,000 Shares |
| Minimum Retail Investment | Rs. 2,16,000 |
| IPO Opens | 31 August 2026 |
| IPO Closes | 2 September 2026 |
| Allotment | 3 September 2026 |
| Listing | 7 September 2026 |
| Exchange | BSE SME |
| Market Capitalisation | Rs. 55.30 Crore |
| Lead Manager | Hem Securities Ltd. |
| Registrar | MUFG Intime India Pvt. Ltd. |
| Market Maker | To Be Updated |
Investor Decision Box
| Question | Chanakya View |
|---|---|
| Suitable for Listing Gain? | π‘ Yes, if GMP remains healthy |
| Suitable for Long-Term? | π‘ Selective |
| Risk Level | Medium to High |
| Business Quality | βββββ |
| Financial Strength | βββββ |
| Balance Sheet | βββββ |
| Valuation Comfort | βββββ |
π | IPO GMP|IPO Reviews |IPO Subscription|IPO Allotment
Chanakya View
Phychem Technologies operates in a specialised segment by manufacturing rotational moulding compounds used in water tanks, chemical tanks, furniture, portable toilets, automotive components and other hollow plastic products. Its customised product portfolio, export presence and established customer relationships provide differentiation from ordinary plastic-product manufacturers.
The companyβs FY25 financial performance was encouraging. Total income increased approximately 7% to Rs. 51.11 crore, while PAT rose sharply by 68% to Rs. 2.84 crore. EBITDA increased to Rs. 4.37 crore, indicating improving operational efficiency. ROE of 34.33% and ROCE of 31.99% are attractive, while the debt-equity ratio of 0.47 remains manageable.
At the upper price of Rs. 54, the post-issue P/E is approximately 19.42 times and market capitalisation is Rs. 55.30 crore. The valuation appears reasonable considering the companyβs improving profitability and return ratios. However, its absolute business scale remains small, PAT margin is only 5.65%, and the minimum retail investment of Rs. 2.16 lakh increases SME-market risk.
The IPO proceeds will support machinery purchases, debt repayment and working capital. These objectives can strengthen both production capacity and the balance sheet. The final decision should depend on GMP, subscription demand and overall SME-market sentiment.
Chanakya Recommendation: π‘ Selective Apply
About the Company
Phychem Technologies manufactures customised polyethylene-based rotational moulding compounds using LLDPE, HDPE and specialised additives. These compounds are supplied in powder or granule form to manufacturers serving the construction, agriculture, water-management, automotive, industrial and consumer-goods sectors.
Its product portfolio includes foam, stone-effect, flame-retardant, anti-static and customised colour compounds. The company also manufactures moulded tanks and provides rotolining and toll-pulverising services.
The manufacturing facility is situated at Khatwad, Dindori, Nashik and contains an in-house laboratory and quality-control department. Phychem is ISO 9001:2015 certified and has received One Star Export House recognition.
The company exports to Bahrain, Bangladesh, Iraq, Kuwait, Nigeria, Saudi Arabia, South Africa, Thailand, Turkey and the UAE, among other markets. It also distributes imported coatings, polypropylene compounds, release agents, process-control equipment, plastic-welding machines and ancillary tools used by the rotational moulding industry.
Why This IPO Stands Out
β Specialised manufacturer of rotational moulding compounds with customised formulations.
β Diversified applications across water management, agriculture, construction and industrial products.
β Established export presence across several international markets.
β FY25 PAT increased 68%, considerably faster than revenue growth.
β Strong ROE of 34.33% and ROCE of 31.99%.
β Entire IPO comprises fresh capital, with no promoter offer for sale.
β Funds will support machinery acquisition, debt reduction and working capital.
β Post-issue P/E of 19.42 times appears reasonable for the reported growth.
Key Risks
β The company operates on a relatively small revenue and profit base.
β PAT margin of 5.65% leaves limited protection against cost pressures.
β Raw-material prices are linked to polymers and petroleum-derived inputs.
β Export operations create currency, logistics and geopolitical risks.
β Competition from domestic and international compound manufacturers may restrict pricing power.
β The minimum retail investment of Rs. 2.16 lakh increases exposure to an illiquid SME stock.
β FY26 financial figures have not been provided, limiting visibility of the latest performance.
Financial Snapshot (Rs. Crore)
| Particulars | FY25 | FY24 | FY23 |
|---|---|---|---|
| Total Income | 51.11 | 47.59 | 43.19 |
| EBITDA | 4.37 | 2.76 | 1.84 |
| PAT | 2.84 | 1.69 | 1.32 |
| Net Worth | 9.70 | 6.86 | 5.16 |
| Borrowings | 4.59 | 5.61 | 4.90 |
Chanakya Interpretation: Revenue growth has been steady rather than exceptional, but EBITDA and PAT expanded strongly during FY25. Net worth improved while borrowings declined, strengthening the balance sheet. Sustaining margins after capacity expansion will be essential.
Business Quality Score
| Parameter | Rating |
|---|---|
| Business Model | βββββ |
| Industry Outlook | βββββ |
| Financial Performance | βββββ |
| Management | βββββ |
| Balance Sheet | βββββ |
| Growth Potential | βββββ |
| Valuation Comfort | βββββ |
IPO Proceeds and Why They Matter
| Purpose | Amount |
|---|---|
| Repayment of outstanding borrowings | Rs. 3.00 Crore |
| Purchase of plant and machinery | Rs. 4.86 Crore |
| Working capital requirements | Rs. 3.00 Crore |
| General corporate purposes | Balance Amount |
Chanakya Interpretation: The utilisation plan is balanced. Machinery investment can increase manufacturing capacity and efficiency, while debt repayment should reduce interest costs and strengthen the balance sheet. Additional working capital will help the company purchase raw materials, maintain inventory and support higher sales. Successful utilisation may improve profitability, but actual benefits will depend on timely installation and adequate demand.
Business Outlook
Rotational moulding compounds are used in water tanks, chemical containers, portable toilets, furniture, automotive components and industrial products. Demand may benefit from infrastructure development, water-storage requirements, agriculture and increasing use of customised plastic products.
Phychemβs specialised formulations, export presence and in-house quality-control facility provide competitive advantages. Its imported-product distribution business also broadens the portfolio. However, polymer prices remain linked to crude oil, and fluctuations can affect margins. Competition, currency movements and slower export demand are additional risks.
Strengths vs Concerns
| π Strengths | β Concerns |
|---|---|
| Specialised product portfolio | Small business scale |
| Diversified end-user industries | PAT margin of only 5.65% |
| Established export presence | Polymer-price volatility |
| Improving profitability | Currency and logistics risks |
| Strong ROE and ROCE | SME liquidity risk |
| Reasonable valuation | Limited latest financial visibility |
Who Should Apply?
| Investor Type | Suitability |
|---|---|
| Listing-Gain Investors | βββββ |
| Long-Term Investors | βββββ |
| Conservative Investors | βββββ |
| High-Risk Investors | βββββ |
Chanakya View: Investors comfortable with SME risks may consider the IPO selectively. Long-term investors may find the specialised business, improving profitability and capacity-expansion plan attractive. Listing-gain applicants should apply only if GMP and subscription demand remain healthy.
Chanakya Final Verdict
Phychem Technologies has developed a niche position in rotational moulding compounds, supported by customised products, international customers and diversified applications. FY25 PAT increased 68%, while EBITDA growth and lower borrowings indicate improving financial quality.
The post-issue P/E of 19.42 times appears reasonable. The use of proceeds for machinery, debt repayment and working capital provides tangible growth triggers.
However, the company remains small, operates with modest margins and is exposed to raw-material volatility. The minimum retail commitment of Rs. 2.16 lakh and limited SME liquidity also increase risk.
Chanakya Recommendation: π‘ Selective Apply
Apply for listing gains only if GMP remains supportive. Long-term investors may consider measured exposure while monitoring capacity utilisation, margins and export growth.
Frequently Asked Questions
What does Phychem Technologies do?
Phychem manufactures customised rotational moulding compounds and provides related industrial services.
What is the Phychem Technologies IPO price band?
The price band is Rs. 51 to Rs. 54 per share.
What is the minimum Phychem Technologies IPO investment?
Individual investors must apply for 4,000 shares, requiring Rs. 2,16,000 at the upper price.
When will Phychem Technologies IPO list?
The tentative BSE SME listing date is 7 September 2026.